Less than four days remain for stakeholders to comment on the highly anticipated bipartisan senate draft 340B program overhaul, and [...] …
Blog Posts
Significant gaps in hospital and health system’s financial data, including 340B program use, “limit transparency for policymakers, researchers, and consumers,” [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal auditors determined terminations from the 340B program were required for either a covered entity site or a contract pharmacy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Q: Where did you grow up?
I grew up in Atlanta, Georgia. As a teenager, I was exposed to several healthcare professional settings, and I had the opportunity to
…
West Virginia Gov. Jim Justice (R) signed into law today a bill to prohibit drugmaker 340B contract pharmacy restrictions, making [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The Kansas state house and senate have passed separate budget bills with late added amendments to prohibit drugmaker 340B contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
After a federal appeals court upheld Arkansas’ 340B contract pharmacy access law, a major drug manufacturer has asked a federal [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
With impending changes like the Senate’s bipartisan SUSTAIN 340B Act on the horizon, it’s becoming increasingly critical for covered entities to demonstrate tangible benefits and positive patient outcomes because of their participation in the 340B program. In the article below, Larry Crowder, Vice President of 340B at Cervey, explores an innovative strategy to ensure compliance and enhance the effectiveness of the 340B program – the cash card.
Understanding Cash Cards: Cash cards allow covered entities (CE) to provide financial assistance directly into the hand of those patients who need it most. These programs typically involve distributing a letter containing payor information – the BIN/PCN associated with a specific insurance or payment network to a patient who meets certain criteria which allows them to receive discounted or free prescriptions at a partnering retail pharmacy. Patients can use these “cards” to receive a lower co-pay and/or drug cost or,
…
An influential conservative congressional caucus is urging Congress to significantly cut Medicaid spending and “ to ensure that drug discounts [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge recently dismissed a large California health system’s whistleblower case against four pharmaceutical companies for alleged fraudulent 340B [...] …